Welcome to our dedicated page for Steakholder Foods Ltd. SEC filings (Ticker: STKH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Steakholder Foods Ltd. filings document the formal disclosures of a foreign private issuer whose securities trade as American depositary shares. The record is centered on Form 6-K reports, registration-statement incorporation, annual meeting results, articles-of-association amendments, board governance matters, ADS-related capital structure, and material agreements.
The filings disclose the company's alternative-protein 3D-printing business, acquisition-related financial statements and pro forma information for Twine Solutions Ltd., operational updates for Twine digital dyeing systems, and financing arrangements such as the Any Market Purchase Agreement equity line of credit. They also document subsidiary-related governance issues and insolvency-proceeding disclosures, alongside resale-registration and equity-incentive registration references.
Steakholder Foods Ltd. (STKH) reports that a special general meeting of shareholders held on September 16, 2026 approved both proposals presented, in accordance with Israeli Companies Law and the company’s articles of association. The meeting had 1,308,636,000 ordinary shares present or represented by proxy, representing approximately 10.75% of issued and outstanding ordinary shares as of the record date.
As part of the approved proposals, the company’s articles of association were amended and restated, covering matters such as share capital, transfer and transmission of shares, conduct of general meetings, board size and procedures, dividend policy, accounts and auditors, indemnification and insurance of office holders, and amendment procedures. The updated articles require that any future amendment receive approval both from the general meeting and from a majority of the then-serving directors. The amended and restated articles are filed as an exhibit and are incorporated by reference into multiple existing F-3 and S-8 registration statements.
Steakholder Foods Ltd. (STKH) reports that its Special General Meeting of Shareholders has been adjourned due to a lack of quorum.
The meeting originally scheduled for September 15, 2026 at 4:00 p.m. Israel time has been moved to September 16, 2026 at the same time and place in Ness Ziona, Israel. Verified holders of ordinary shares may still vote by returning a proxy card in advance or by voting in person. The deadline set by The Bank of New York Mellon for voting instructions from holders of American Depositary Shares has passed, so ADS holders can no longer vote the ordinary shares represented by their ADSs at this Meeting.
Steakholder Foods Ltd. (STKH) announced the commercial launch of its Perfecta™ Premium Plant-Based Meat line at retail locations across the Northeastern United States, its first placement on U.S. store shelves. Distribution is being handled through KeHE Distributors, a major U.S. natural and specialty food distributor.
The launch is part of a phased strategy focused on building brand awareness and consumer trial in the Northeast while laying groundwork for broader U.S. expansion and additional distribution partnerships. Perfecta is positioned as a next-generation plant-based protein platform offering both whole-cut and traditional formats designed to closely replicate meat and seafood taste, texture, and appearance, supported by Steakholder Foods’ 3D-printing technology and proprietary premix blends.
Steakholder Foods Ltd. (STKH) reported unaudited results for the six months ended June 30, 2026, showing an early‑stage business still pre‑revenue but expanding commercialization efforts. Revenue remained $0, while a first‑time inventory write‑off drove cost of goods sold of $0.3 million and a total comprehensive loss of $3.3 million, down 15% from $3.8 million a year earlier.
Operating expenses shifted: research and development fell 33% to $0.8 million and general and administrative declined 19% to $1.6 million, while marketing rose to $0.6 million as the company prepared its U.S. launch of the Perfecta plant‑based meat platform and continued development and sales of 3D‑printing production machines. Cash and cash equivalents were $1.1 million at June 30, 2026 versus $3.1 million at year‑end 2025, with an accumulated deficit of $93.2 million and shareholders’ equity of $2.27 million.
Management states there is substantial doubt about the company’s ability to continue as a going concern because existing cash is not sufficient for at least 12 months. Subsequent to June 30, 2026, Steakholder Foods raised about $4.3–4.7 million net through a July 2026 private placement, warrant exercises and use of an $8.0 million equity line, and estimates pro forma shareholders’ equity of ~$6.57 million, above Nasdaq’s $2.5 million equity requirement. The company also discloses risk that its Market Value of Listed Securities, approximately $4.8 million on August 20, 2026, could trigger future Nasdaq delisting under a proposed new rule if implemented.
Steakholder Foods Ltd. (STKH) filed a resale prospectus covering up to 5,372,500 American Depositary Shares (ADSs), each ADS representing 12,000 Ordinary Shares. The ADSs consist of up to 1,750,000 issuable upon exercise of Pre-Funded Warrants, 1,750,000 from Series E Warrants, 1,750,000 from Series F Warrants, and 122,500 from Placement Agent Warrants issued in a July 2026 private placement.
The company will not receive proceeds from selling shareholders’ ADS resales but may receive up to $7.02 million if all related warrants are exercised for cash, to be used for research and development, business growth, and general corporate purposes. Ordinary shares outstanding were 13,363,552,659 (about 1,113,629 ADSs) as of August 12, 2026, and would rise to 77,833,552,659 (about 6,486,129 ADSs) if all such warrants are fully exercised. Steakholder Foods discloses Nasdaq listing risks, including a contemplated $5.0 million minimum Market Value of Listed Securities threshold versus its $3.8 million MVLS, and auditors have included a going-concern explanatory paragraph citing significant losses, negative operating cash flows and an accumulated deficit.
Steakholder Foods Ltd. (symbol STKH) has filed a pre‑effective amendment to a Form F‑3 registration statement to register the resale of up to 5,372,500 American Depositary Shares (ADSs) by existing selling shareholders. Each ADS represents 12,000 Ordinary Shares. The ADSs are issuable upon exercise of Pre‑Funded Warrants, Series E Warrants, Series F Warrants and Placement Agent Warrants issued in a July 2026 private placement.
The company will not receive proceeds from resale of these ADSs; all resale proceeds go to the selling shareholders. Steakholder Foods may receive up to $7.02 million in gross proceeds only if all related warrants are exercised for cash, which it plans to use for research and development, business growth, working capital and general corporate purposes. Ordinary Shares outstanding were 13,363,552,659 (about 1,113,629 ADSs) as of August 12, 2026, and would be 77,833,552,659 (about 6,486,129 ADSs) assuming full exercise of these warrants.
The ADSs trade on the Nasdaq Capital Market under the symbol STKH, with a last reported price of $3.60 per ADS on August 14, 2026. Steakholder Foods highlights risks including potential pressure on the ADS price from resale of a substantial number of ADSs and the risk of Nasdaq delisting, noting its Market Value of Listed Securities was approximately $3.8 million as of August 12, 2026, below a contemplated $5.0 million minimum MVLS standard whose implementation remains subject to SEC review.
Steakholder Foods Ltd. filed a resale Form F-3 covering up to 5,372,500 American Depositary Shares (ADSs), each representing 12,000 Ordinary Shares. The ADSs are issuable upon exercise of pre-funded, Series E, Series F and placement agent warrants issued in a July 2026 private placement.
The company will not receive proceeds from ADS resales by the selling shareholders, but could receive up to $7.02 million if all registered warrants are exercised for cash, which it plans to use for research and development, business growth, and general working capital. Ordinary Shares outstanding were 13,363,552,659, represented by about 1,113,629 ADSs, as of August 12, 2026, and would increase to 77,833,552,659 Ordinary Shares (about 6,486,129 ADSs) assuming full exercise of the registered warrants.
The prospectus highlights risks from potential selling pressure from these resales and from compliance with Nasdaq listing standards, including a proposed $5.0 million Market Value of Listed Securities requirement versus the company’s $3.8 million MVLS as of August 12, 2026.
Steakholder Foods Ltd. is calling a Special General Meeting on September 15, 2026 in Ness Ziona, Israel. Shareholders will vote on two key items: (1) an increase in authorized share capital and (2) approval to issue American Depositary Shares (ADSs) underlying pre-funded warrants from a July 2026 private placement.
In that financing, the company issued Pre-Funded Warrants and Series E and F Warrants to purchase up to 1,750,000 ADSs each, at a combined purchase price of $1.99 per pre-funded unit, generating approximately $3.5 million in gross proceeds. Each ADS represents 12,000 ordinary shares. Current authorized share capital is 50,000,000,000 ordinary shares, with 12,173,080,659 ordinary shares outstanding as of August 5, 2026.
The board proposes increasing authorized capital by 999,950,000,000,000 to a total of 1,000,000,000,000,000 ordinary shares to enable full exercise of the new and existing warrants and provide additional capacity for future needs. Shareholders are also asked to approve issuance of all ordinary shares underlying the pre-funded warrants, which, if fully exercised, would result in 1,750,000 ADSs (21,000,000,000 ordinary shares) for the investor, potentially making it a controlling shareholder under Israeli law.
Steakholder Foods Ltd. entered into a definitive securities purchase agreement for a private placement of pre-funded warrants and unregistered Series E and Series F warrants, each series covering up to 1,750,000 ADSs, with each ADS representing 12,000 ordinary shares. The transaction closed on August 3, 2026, generating approximately $3.5 million in gross proceeds, assuming full exercise of the pre-funded warrants.
The Series E and F warrants have an exercise price of $2.00 per ADS, become exercisable after shareholder approval of an authorized share increase, and expire 18 months and five years, respectively, after the later of the resale registration effectiveness and that approval. If fully exercised in cash, the warrants could provide approximately $7 million in additional gross proceeds. Use of proceeds is for research and development, business growth, working capital and general corporate purposes.
Warrants include a 4.99% beneficial ownership cap and allow cashless exercise for Ordinary Warrant ADSs if no effective resale registration exists. H.C. Wainwright & Co. acted as exclusive placement agent, earning a 7.5% cash fee, expense reimbursements and 122,500 placement agent warrants at $2.50 per ADS. The company agreed to near-term restrictions on additional issuances and to avoid “variable rate transactions” for one year, and entered into a Registration Rights Agreement to register the warrant ADSs for resale.